Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
Become a Member | Sign in
Home>News>This Article

Agilent Technologies and Ameritox Form Collaboration

Published: Tuesday, February 12, 2013
Last Updated: Tuesday, February 12, 2013
Bookmark and Share
Agilent Technologies Inc. and AmeritoxSM announced that they have formed a research collaboration that could accelerate analysis in the field of medication monitoring.

“By using multiple RapidFire systems Ameritox is streamlining the analysis of small panels of exogenous compounds compared to traditional methods of analysis,” said Can Ozbal, director of Agilent’s RapidFire business.

While Agilent’s RapidFire system has been used extensively in pharmaceutical and biopharmaceutical laboratories, this research collaboration with Ameritox is one of the first for Agilent’s RapidFire team in the field of medication monitoring.

“By working together and sharing moment-by-moment laboratory activity, this research arrangement gives both Ameritox and Agilent a vantage point from which we can continue to discover new uses for our science and technology,” said Jay Zimmerman, chief laboratory officer of Ameritox.

“The marriage of Agilent’s technology and Ameritox’s proprietary science could hold the key to major advancements in the field of medication monitoring,” Zimmerman said.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Agilent Collaborating with Florida International University
Collaboration to further advance the identification and characterization of designer drugs.
Tuesday, February 26, 2013
Agilent and Johns Hopkins to Research Toxicity Pathways for Embryonic Brain Development Using Metabolomics
The work could help identify possible contributions of chemicals to disorders such as autism and attention hyperactivity disorders.
Friday, August 20, 2010
Agilent and National Institute for Bioprocessing Research and Training, Advance Emerging Glycomics Research
NIBRT's Professor Pauline Rudd has been granted an Agilent Thought Leader Award in support of her emerging glycomics research.
Wednesday, June 30, 2010
Agilent Instruments Selected by South African Doping Control Laboratory for 2010 World Cup
The Company has been selected by as the primary provider of gas-phase testing instruments for the 2010 World Cup.
Wednesday, June 16, 2010
BIOCIUS and Agilent Launch High-throughput, RapidFire® Mass Solution for Drug Discovery
Advanced, integrated system for high quality in vitro ADME analysis unveiled at ASMS Conference, May 23-May 27.
Friday, May 21, 2010
Agilent and the National Center for Food Safety and Technology Collaborate to Develop Food Testing Methods
The collaboration will develop new scientific methods for food testing to solve problems facing global food supply chains.
Wednesday, March 03, 2010
Novel Automated Stem Cell High Content Screening Platform
A new technical poster describes how researchers at I-STEM have used a BioCel 1800 platform for muscular dystrophy therapeutic research.
Friday, June 19, 2009
Agilent Introduces Service to Help GC and LC Labs Demonstrate Test Quality and Calibration
Service leverages expertise in Pharma into chemical, food, flavors, forensics, other labs seeking ISO/IEC 17024-type certification.
Wednesday, June 17, 2009
Agilent Technologies and Anderson Forschung Group Collaborate on Quantitative Protein Assays
The collaboration will combine AFG’s SISCAPA technology with Agilent’s HPLC-Chip and triple quadrupole MS to speed protein biomarker discovery and validation.
Wednesday, June 03, 2009
Agilent Technologies Completes Large-Scale Expansion of Nucleic Acid Manufacturing Capacity
Major expansion enables the company to manufacture several hundred kilograms of therapeutic oligonucleotides per year.
Friday, May 08, 2009
Agilent Technologies Hosts Anti-Doping Agency Officials
The China Anti-Doping Agency to use Agilent instrumentation to confirm the chemical identity of suspected banned substances found in testing samples.
Friday, May 23, 2008
Agilent Technologies Acquires Kalabie Electronic Laboratory Notebook from Klee Group
Agilent expands informatics portfolio with electronic notebook for life sciences, chemical analysis after acquiring Kalabie.
Tuesday, June 19, 2007
Regulators OK Agilent buy of Stratagene
Federal Antitrust Regulators Approve Agilent's Purchase of Stratagene
Monday, May 14, 2007
Agilent Technologies Announces Creation of new Business Unit in Life Sciences and Chemical Analysis
The new business unit will focus on developing a microscopy and optical spectroscopy business that can be leveraged into the electronics, materials testing, life sciences and chemical analysis markets.
Monday, April 02, 2007
Agilent Launches Life Science and Chemical Analysis Centers of Excellence
Demonstration centers highlight Agilent’s full portfolio of life sciences and chemical analysis capabilities.
Tuesday, December 05, 2006
Scientific News
Atriva Therapeutics GmbH Develops Innovative Flu Drug
Highly effective against seasonal and pandemic influenza.
Study Removes Cancer Doubt for Multiple Sclerosis Drug
Researchers from Queen Mary University of London are calling on the medical community to reconsider developing a known drug to treat people with relapsing Multiple sclerosis after new evidence shows it does not increase the risk of cancer as previously thought.
New Hope for Personalized Treatment of Eczema
Pharmaceutical researchers at Oregon State University have developed a new approach to treat eczema and other inflammatory skin disorders that would use individual tests and advanced science to create personalized treatments based on each person's lipid deficiencies.
Inroads Against Leukaemia
Potential for halting disease in molecule isolated from sea sponges.
Researchers Disguise Drugs As Platelets to Target Cancer
Researchers have for the first time developed a technique that coats anticancer drugs in membranes made from a patient’s own platelets.
HIV Patients Should Be Included in Early Clinical Trials of Anti-TB Drugs
Tuberculosis is the number one cause of death in HIV-infected patients in Africa and a leading cause of death in this population worldwide.
Combination Drug Therapy Shrinks Pancreatic Tumors In Mice
Two drugs that affect the structure and function of DNA have been found to block the growth of pancreatic tumor cells in mice, researchers hope the drugs can soon be tested in humans with the disease.
Seeking A Better Way To Design Drugs
NIH funds research at Worcester Polytechnic Institute to advance a new chemical process for more effective drug development and manufacturing.
Old Drug Performs New Tricks
Cambridge-led research reveals the powers of a "wonder drug" that has lain under the noses of doctors for 50 years.
Diabetes Drugs May Actually Release Sugar Into the Blood
A family of drugs used to treat Type 2 diabetes could promote the release of sugars into the blood - something the drugs are supposed to prevent, Cambridge scientists have claimed.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos